Budesonide orodispersible tablets are superior to maintain and even further improve quality of life in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Christoph Schlag  1     Luc Biedermann  2     Alfredo J. Lucendo  3     Stephan Miehlke  4     Cecilio Santander Vaquero  5     Constanza Ciriza De Los Ríos  6     Dirk Hartmann     Ahmed Madisch     Petr Hruz     Jamal Hayat     Ulrike von Arnim     Arjan Bredenoord     Ralph Müller     Roland Greinwald     Alain Schoepfer     Stephen E. Attwood     Alex Straumann    
1 Technische Universität München,München,Germany
2 USZ Zürich,Zürich,Switzerland
3 Hospital General de Tomelloso Dept. of Digestive Health,Tomelloso,Spain
4 Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany
5 Hospital Universitario de La Princesa,Madrid,Spain
6 Hospital

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing